These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 9353423)

  • 1. Taxol-mediated changes in fibrosarcoma-induced immune cell function: modulation of antitumor activities.
    Mullins DW; Walker TM; Burger CJ; Elgert KD
    Cancer Immunol Immunother; 1997 Oct; 45(1):20-8. PubMed ID: 9353423
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Taxol, a microtubule-stabilizing antineoplastic agent, differentially regulates normal and tumor-bearing host macrophage nitric oxide production.
    Mullins DW; Alleva DG; Burger CJ; Elgert KD
    Immunopharmacology; 1997 Aug; 37(1):63-73. PubMed ID: 9285245
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Paclitaxel enhances macrophage IL-12 production in tumor-bearing hosts through nitric oxide.
    Mullins DW; Burger CJ; Elgert KD
    J Immunol; 1999 Jun; 162(11):6811-8. PubMed ID: 10352302
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interleukin-12 overcomes paclitaxel-mediated suppression of T-cell proliferation.
    Mullins DW; Koci MD; Burger CJ; Elgert KD
    Immunopharmacol Immunotoxicol; 1998 Nov; 20(4):473-92. PubMed ID: 9805229
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased sensitivity of tumor-bearing host macrophages to interleukin-10: a counter-balancing action to macrophage-mediated suppression.
    Alleva DG; Burger CJ; Elgert KD
    Oncol Res; 1994; 6(4-5):219-28. PubMed ID: 7841545
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumor growth modulates macrophage nitric oxide production following paclitaxel administration.
    Mullins DW; Burger CJ; Elgert KD
    Int J Immunopharmacol; 1998 Oct; 20(10):537-51. PubMed ID: 9839658
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumor-induced regulation of suppressor macrophage nitric oxide and TNF-alpha production. Role of tumor-derived IL-10, TGF-beta, and prostaglandin E2.
    Alleva DG; Burger CJ; Elgert KD
    J Immunol; 1994 Aug; 153(4):1674-86. PubMed ID: 8046239
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tumor growth increases Ia- macrophage synthesis of tumor necrosis factor-alpha and prostaglandin E2: changes in macrophage suppressor activity.
    Alleva DG; Burger CJ; Elgert KD
    J Leukoc Biol; 1993 May; 53(5):550-8. PubMed ID: 8388910
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Induction of macrophage suppressor activity by fibrosarcoma-derived transforming growth factor-beta 1: contrasting effects on resting and activated macrophages.
    Alleva DG; Walker TM; Elgert KD
    J Leukoc Biol; 1995 Jun; 57(6):919-28. PubMed ID: 7790775
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Taxol provides a second signal for murine macrophage tumoricidal activity.
    Manthey CL; Perera PY; Salkowski CA; Vogel SN
    J Immunol; 1994 Jan; 152(2):825-31. PubMed ID: 7506736
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumor modulation of autoreactivity: decreased macrophage and autoreactive T cell interactions.
    Yurochko AD; Burger CJ; Elgert KD
    Cell Immunol; 1990 Apr; 127(1):105-19. PubMed ID: 2138515
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fibrosarcoma-induced increase in macrophage tumor necrosis factor alpha synthesis suppresses T cell responses.
    Alleva DG; Askew D; Burger CJ; Elgert KD
    J Leukoc Biol; 1993 Aug; 54(2):152-60. PubMed ID: 8360594
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Soluble factor from murine bladder tumor-2 cell elevates nitric oxide production in macrophages and enhances the taxol-mediated macrophage cytotoxicity on tumor cells.
    Choi SC; Oh HM; Park JS; Han WC; Yoon KH; Kim TH; Yun KJ; Kim EC; Nah YH; Cha YN; Chung HT; Jun CD
    Cancer Invest; 2003; 21(5):708-19. PubMed ID: 14628429
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Macrophage-derived prostaglandin E modulation of the mixed-lymphocyte reaction: an anomaly of increased production and decreased T-cell susceptibility during tumor growth.
    Denbow CJ; Conroy JM; Elgert KD
    Cell Immunol; 1984 Mar; 84(1):1-13. PubMed ID: 6230157
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Involvement of protein kinase C during taxol-induced activation of murine peritoneal macrophages.
    Jun CD; Choi BM; Kim HM; Chung HT
    J Immunol; 1995 Jun; 154(12):6541-7. PubMed ID: 7759887
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tumor growth alters macrophage responsiveness to macrophage colony-stimulating factor during reactivity against allogeneic and syngeneic MHC class II molecules.
    Walker TM; Burger CJ; Elgert KD
    Immunol Invest; 1993; 22(6-7):463-76. PubMed ID: 8262568
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Post-chemotherapeutic administration of interleukin-12 retards tumor growth and enhances immune cell function: combination therapy using paclitaxel and IL-12.
    Pressley JS; Elgert KD
    Cancer Invest; 2006; 24(4):351-9. PubMed ID: 16777686
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Activation and regulation of macrophages induced by inoculation of cryodestroyed tumor cells].
    Tsujino M
    Osaka Daigaku Shigaku Zasshi; 1990 Jun; 35(1):180-205. PubMed ID: 2135404
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interferon-gamma reduces tumor-induced Ia- macrophage-mediated suppression: role of prostaglandin E2, Ia, and tumor necrosis factor-alpha.
    Alleva DG; Burger CJ; Elgert KD
    Immunopharmacology; 1993; 25(3):215-27. PubMed ID: 8354638
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The antitumoral effect of the immunomodulator AS101 and paclitaxel (Taxol) in a murine model of lung adenocarcinoma.
    Kalechman Y; Shani A; Dovrat S; Whisnant JK; Mettinger K; Albeck M; Sredni B
    J Immunol; 1996 Feb; 156(3):1101-9. PubMed ID: 8557985
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.